FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 731 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up August 5, 2025 Mom Fights Second Round Of Breast Cancer — Weeks Later, Her... September 13, 2019 Delayed irAEs Occur in a Small Subset of Patients with Melanoma,... April 1, 2021 A Clinical Signal of Efficacy Observed with a Combination of Nivolumab... June 20, 2022 Load more HOT NEWS NHS lung cancer patients in England to get early access to... How to Improve Cancer-Related Fatigue Using Exercise: Expert Perspectives How do we die of cancer? What we know (and what... Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of...
